The table below shows Bioventus Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$8.93M
-$19.33M
-$6.00M
$2.49M
-$21.02M
-$18.04M
Capital expenditure
$574.00K
$826.00K
$291.00K
$3.56M
$2.96M
$1.37M
Investing cash flow
-$574.00K
-$826.00K
-$1.00M
-$15.07M
-$4.67M
-$46.65M
Dividends paid
-
-
-
-
BVS operating cash flow (10-K history)
Bioventus Inc. reported operating cash flow of $74.67M for fiscal year 2025. That is up 92.5% from $38.80M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow grew from $40.71M (FY 2019) to $74.67M. Figures come from the company's audited annual reports as filed with the SEC.